Advertisement

Topics

Certara advances global initiative to take model-informed precision dosing (MIPD) into the clinic

19:00 EST 6 Feb 2019 | AAAS

(Rana Healthcare Solutions LLC) Certara recognized several years ago that model-informed drug development could also provide tremendous value if used by healthcare providers to determine the optimal drug dose for individual patients in the clinic. Certara scientists have been engaged in critical assessments of hurdles to model-informed precision dosing (MIPD) and have published four new papers in the past months delineating the vision and practical path(s) for making individualized dosing a reality under the efforts for 'Precision Medicine.'

Original Article: Certara advances global initiative to take model-informed precision dosing (MIPD) into the clinic

NEXT ARTICLE

More From BioPortfolio on "Certara advances global initiative to take model-informed precision dosing (MIPD) into the clinic"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...